Pharmvit Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

Registered number: 01455949

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		856,338		856,338
Tangible Assets	5		2,189,516		2,117,492
Investments	6		17,064		17,064

			3,062,918		2,990,894
CURRENT ASSETS
Stocks	7	991,300		962,500
Debtors	8	2,350,159		2,187,800
Cash at bank and in hand		58,683		53,710

		3,400,142		3,204,010
Creditors: Amounts Falling Due Within One Year	9	(6,535,108 )		(6,077,051 )

NET CURRENT ASSETS (LIABILITIES)			(3,134,966 )		(2,873,041 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(72,048 )		117,853

Creditors: Amounts Falling Due After More Than One Year	10		(305,713 )		(233,763 )

NET LIABILITIES			(377,761 )		(115,910 )

CAPITAL AND RESERVES
Called up share capital	11		1,000		1,000
Revaluation reserve	12		519,705		519,705
Profit and Loss Account			(898,466 )		(636,615 )

SHAREHOLDERS' FUNDS			(377,761)		(115,910)

Page 1

Page 2

Pharmvit Limited

Balance Sheet (continued)

As At 31 August 2025

For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr K Latif

Director

27/05/2026

The notes on pages 3 to 6 form part of these financial statements.

1. General Information

Pharmvit Limited is a private company, limited by shares, incorporated in England & Wales, registered number 01455949 . The registered office is 177 Bilton Road, Greenford, Middlesex, UB6 7HQ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Intangible Fixed Assets and Amortisation - Other Intangible

Other intangible assets are .... It is amortised to the profit and loss account over its estimated economic life of .... years.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Freehold	0
Leasehold	5%
Plant & Machinery	5%
Motor Vehicles	25%
Fixtures & Fittings	5%

2.5. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

Page 3

Page 4

Pharmvit Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 August 2025

3. Average Number of Employees

Average number of employees, including directors, during the was:2023 22 (2024: 22)

4. Intangible Assets

	Other
	£
Cost
As at 1 September 2024	856,338

As at 31 August 2025	856,338

Net Book Value
As at 31 August 2025	856,338

As at 1 September 2024	856,338

5. Tangible Assets

	Land & Property
	Freehold	Leasehold	Plant & Machinery	Fixtures & Fittings	Total
	£	£	£	£	£
Cost
As at 1 September 2024	897,180	53,927	1,157,327	1,042,116	3,150,550
Additions	-	-	118,460	26,040	144,500

As at 31 August 2025	897,180	53,927	1,275,787	1,068,156	3,295,050

Depreciation
As at 1 September 2024	-	46,030	666,335	320,693	1,033,058
Provided during the period	-	395	34,708	37,373	72,476

As at 31 August 2025	-	46,425	701,043	358,066	1,105,534

Net Book Value
As at 31 August 2025	897,180	7,502	574,744	710,090	2,189,516

As at 1 September 2024	897,180	7,897	490,992	721,423	2,117,492

Page 4

Page 5

Pharmvit Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 August 2025

6. Investments

	Listed
	£
Cost or Valuation
As at 1 September 2024	17,064

As at 31 August 2025	17,064

Provision
As at 1 September 2024	-

As at 31 August 2025	-

Net Book Value
As at 31 August 2025	17,064

As at 1 September 2024	17,064

7. Stocks

	2025	2024
	£	£
Stock	991,300	962,500

8. Debtors

	2025	2024
	£	£
Due within one year
Trade debtors	303,538	264,080
Other debtors	2,046,621	1,923,720

	2,350,159	2,187,800

9. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	1,112,764	1,098,326
Other creditors	5,377,523	4,947,039
Taxation and social security	44,821	31,686

	6,535,108	6,077,051

Page 5

Page 6

Pharmvit Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 August 2025

10. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Bank Loan- Edgars loan	305,713	233,763

11. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	1,000	1,000

12. Reserves

	Revaluation reserve	Profit and Loss Account
	£	£
As at 1 September 2024	519,705	(636,615 )
Loss for the year and total comprehensive income	-	(261,851 )

As at 31 August 2025	519,705	(898,466 )

Page 6